ArticleBMC infectious diseases2025

Assessment of in vitro antimicrobial activities of ceftolozane/tazobactam and ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa clinical isolates.

Dalia Salem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.